- Fund Information
ALPS Medical Breakthroughs ETF: (SBIO)
(Delayed Data from NYSE) As of Mar 26, 2019 03:58 PM ET
$35.54 USD
+0.57 (1.63%)
Volume: 22,264
Zacks ETF Rank 3 - Hold 3
This is our ETF rating system that serves as a timeliness indicator for ETFs over the next 6 months:
| Zacks Rank | Definition |
|---|---|
| 1 | Strong Buy |
| 2 | Buy |
| 3 | Hold |
| 4 | Sell |
| 5 | Strong Sell |
See all the Top Ranked ETFs here - The complete list of all the top ranked ETFs
ETF Quote Details
| Previous Close | 34.97 |
| Open | 35.23 |
| Bid | 25.00 |
| Ask | 36.00 |
| Day Low-High | 35.12-35.58 |
| 52wk Low-High | 25.49-39.61 |
| Volume | 22,264 |
| NAV (month end) | 34.45 |
| Premium (+)/Discount (-) (month end) | +0.52 |
ETF Expense Ratio
| Expense Ratio | 0.50% |
| Dividend (Yield) | $0.78 (2.21%) |
| Issuer | ALPS |
Benchmark for SBIO
POLIWOGG MEDICAL BREAKTHROUGHS INDEX
The Poliwogg Medical Breakthroughs Index captures research & development opportunities in the pharmaceutical industry. It consists of small-cap and mid-cap pharmaceutical and biotechnology stocks listed on US stock exchanges that have one or more drugs in either Phase II or Phase III US FDA clinical trials.
Fund Summary for SBIO
ALPS MEDICAL BREAKTHROUGHS ETF
The ALPS Medical Breakthroughs ETF seeks investment results that correspond, before fees and expenses, to the performance of Poliwogg Medical Breakthroughs Index.

